Fasting blood glucose is a novel prognostic indicator for extranodal natural killer|[sol]|T-cell lymphoma, nasal type

摘要

Background:Extranodal natural killer (NK)/T-cell lymphoma, nasal type (ENKTL) is an aggressive disease with poor prognosis, requiring risk stratification. However, the prognosis of ENKTL is not fully defined and needs supplementation. We hypothesised that fasting blood glucose (FBG) may be a new prognostic factor for ENKTL.